Using bio-polymers and the same short-range NFC (near-field communication) technology as contactless payment cards, the implant from Polish-British startup Walletmor can be sewn into the hand and used to make payments at all contactless terminals around the world that accept payments with standard cards from organizations such as Mastercard or Visa.
VIDEO: Selected as the best youth city for 2023, Lublin beat off competition from five other European cities including Poznań, Lviv, Baia Mare, Izmir and Kazań.
Dubbed the future face of libraries in which ‘culture meets the sustainable lifestyle’, the creations by GK-Atelier Grzegorz Kłoda have set the design world aflutter.
The design of the station’s buildings will include eco-friendly solutions to make the station self-sufficient in energy as well as smog-fighting paving slabs, which will convert toxic exhaust fumes into harmless substances, a wall of air-cleaning plants on the roof of the planned parking and a rainwater collection system.
VIDEO: The European Commission's Innovation Radar is about finding excellence across all EU funded research with over 2,000 projects receiving investment from Horizon 2020, the EU’s research and innovation programme.
The drug, made by fractionating the plasma of people who were recovering from Covid-19 or who had it asymptomatically, contains anti-SARS-CoV-2 immunoglobulins that can fight and neutralise the deadly virus.
Polish PM Mateusz Morawiecki welcomed his Visegrad Group (V4) counterparts in Lublin, eastern Poland, on Friday noon, before a meeting planned to focus on the forthcoming extraordinary EU summit and the situations in Belarus and Russia.
Jewish tradition will be presented through music, performances, meetings and educational activities at the Lubliner Festiwal, the 1st Jewish Culture Festival, in Lublin, eastern Poland, which begins on Tuesday.
The discovery could be a major breakthrough in bee conservation and not only save bees around the world but also help protect the variety of ecosystems that they contribute to.
Biomed Lublin has started production of the first batch of a drug for COVID-19 from convalescent plasma. It will be subjected to clinical trials that will begin in about two months, said representatives of Biomed and the Medical University of Lublin on Tuesday.